Navigation Links
Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
Date:8/6/2008

s early as two minutes after dosing with AZ-007. There were no serious adverse events. The most frequently reported adverse events in subjects receiving AZ-007 were dizziness and somnolence. These data indicate a rapid onset of effect, apparently directly related to the IV-like pharmacokinetics, and showed that AZ-007 was generally safe and well tolerated in this population of healthy volunteers.

Conference Call Information

Alexza will host a conference call tomorrow morning, Thursday, August 7, 2008 at 8:45 a.m. Eastern Time. A replay of the call will be available for two weeks following the event. The conference call, replay and webcast are open to all interested parties.

To access the conference call via the Internet, go to http://www.alexza.com, under the "Investor Relations" link. Please join the call at least 15 minutes prior to the start of the call to ensure time for any software downloads that may be required. Interested parties may also pre-register to avoid pre-call delays at https://www.theconferencingservice.com/prereg/key.process?key=PHY9DE66U.

To access the live conference call via phone, dial 888-680-0894. International callers may access the live call by dialing 617-213-4860. The reference number to enter the call is 37382979.

The replay of the conference call may be accessed via the Internet, at http://www.alexza.com, or via phone at 888-286-8010 for domestic callers or 617-801-6888 for international callers. The reference number for the replay of the call is 47372481.

About Alexza Pharmaceuticals

Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Thirty-six million Americans suffer from hearing loss, ... National Hearing Month – more than 28 million Americans ... the sounds of spring, like birds singing and the ... that you won,t be among those missing out on ... offers practical advice: Take action if you ...
(Date:5/4/2015)... -- Impax Laboratories, Inc. (NASDAQ: IPXL ) announced that ...  Donna M. Hughes, as Senior Vice President, Human Resources ... President, Chief Compliance Officer. Both Ms. Hughes and Ms. ... Officer, Fred Wilkinson . "We are ... team," said Fred Wilkinson , President and Chief ...
(Date:5/4/2015)... Bayer HealthCare (Bayer) has entered into an ... ISIS ) on ISIS-FXI Rx, an antisense investigational ... Under the agreement Bayer will further develop and commercialize ... need. As part of the clinical development program, Bayer ... in an appropriate patient community. "Bayer ...
Breaking Medicine Technology:It's Better Hearing Month 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 3Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3
... Sept. 2 NewCardio (OTC Bulletin Board: NWCI ... Renz, Jr., NewCardio,s President and CEO, purchased 128,000 shares during ... weeks following the Company,s filing of its SEC Form 10-Q ... 2010. "As discussed on our August 12, ...
... SKILLMAN, N.J., Sept. 2 ConvaTec, a world-leading developer ... hospital care, announced today the introduction of a new, ... with Strengthening Fibers, now available in the U.S. and ... highly exuding chronic and acute wounds. The new dressing, ...
Cached Medicine Technology:NewCardio CEO Increases Equity Position 2NewCardio CEO Increases Equity Position 3NewCardio CEO Increases Equity Position 4ConvaTec Expands AQUACEL® Dressing Product Line With Introduction of New Ribbon Dressing 2ConvaTec Expands AQUACEL® Dressing Product Line With Introduction of New Ribbon Dressing 3ConvaTec Expands AQUACEL® Dressing Product Line With Introduction of New Ribbon Dressing 4
(Date:5/4/2015)... New York, NY (PRWEB) May 04, 2015 ... the 2015 International Champions Cup (ICC) . While ... the world and is held every four years, the International ... Last year, the tournament saw the all-time attendance record for ... Real Madrid from the Big House at the University of ...
(Date:5/4/2015)... City, OK and Seattle, WA (PRWEB) May 04, 2015 ... announced the formation of a collaboration to facilitate development ... number of ophthalmic disorders that lead to blindness, including ... to the MiDROPS™ formulation platform developed by EyeCRO, which ... the eye via a topical eyedrop. , Under ...
(Date:5/4/2015)... VA (PRWEB) May 04, 2015 Ticket Down ... at the John Paul Jones Arena in Charlottesville, VA. ... the history of the music business and this beloved performer ... Paul McCartney, the former member of two legendary groups: Wings ... in the music business since 2013 on the “Out There” ...
(Date:5/4/2015)... May 04, 2015 New findings released ... Tumor Association (ABTA) show that people diagnosed with a ... treatment options, including clinical trials, at the time of ... make difficult decisions about their course of treatment. The ... the first nationwide brain tumor volunteer network, the ABTA ...
(Date:5/4/2015)... 2015 Pricing Healthcare announces it ... one patient receiving care at St. George Surgical Center ... must be performed by July 15th, 2015, and the patient ... up front and forego the filing of insurance claims). , ... every year, and it devastates more and more individuals and ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3
... in patients with metastatic breast cancer, especially in those ... epidermal growth factor receptor-2) positive, a surgical oncologist will ... Breast Cancer Conference (EBCC7). Dr Marie Sundquist, ... will say that the median survival times for five-year ...
... ... leading Pediatrician Dr. William Lawrence Jr. of Sixty Second Parent encouraged parents to continue ... ... National Nutrition Month draws to a close, leading Pediatrician Dr. William Lawrence Jr. of ...
... ... of Shimmering Resumes, offers to help former Bush speechwriter David Frum with his resume. ... strategy on healthcare reform. , ... (PRWEB) March 26, 2010 -- Paul Freiberger, the President of Shimmering Resumes, ...
... ... accidents , ... March 26, 2010 -- With the arrival of spring, more cyclists are planning to enjoy the ... people sharing the road with drivers and pedestrians., , , , ,This week bikers complained to ...
... ... disorders and improve dental procedures. , ... Miami, FLA. (PRWEB) -- In addition to cosmetic dentistry services, including veneers and ... Institute now offer dental massage to patients. Dr. Nassery teams up with Love Life Massage, ...
... Women who discover they have breast cancer while they ... the health of their unborn baby, according to research ... Conference (EBCC7) in Barcelona today (Friday). Dr Sibylle ... University of Frankfurt, Germany, and a member of the ...
Cached Medicine News:Health News:Survival in metastatic breast cancer patients is improving: targeted therapies have contributed 2Health News:Eating Habits Start Early - Parents must be Good Role Models for Healthy Kids 2Health News:President of Shimmering Resumes Offers Professional Resume To Bush Speechwriter, David Frum 2Health News:New York Personal Injury Attorney Interprets Increase in Tickets for Cyclists as Effort to Make Streets Safer 2Health News:Top Miami Dentist, Dr. Hamid Nassery, Offers Dental Massage Services For Patients 2Health News:Pregnant women can receive breast cancer chemotherapy without endangering health of their babies 2Health News:Pregnant women can receive breast cancer chemotherapy without endangering health of their babies 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: